Lee Ainslie Elanco Animal Health Inc Transaction History

Maverick Capital LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$14.37 - $16.46 $342,192 - $391,961	23,813 New	23,813 $387,000
Q1 2022 May 16, 2022	SELL	$24.65 - $29.0 $57,409 - $67,541	-2,329 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$27.74 - $34.09 $336,513 - $413,545	-12,131 Reduced 83.89%	2,329 $66,000
Q3 2021 Nov 15, 2021	BUY	$29.2 - $36.72 $422,232 - $530,971	14,460 New	14,460 $461,000
Q2 2021 Aug 16, 2021	SELL	$28.76 - $35.98 $49.4 Million - $61.8 Million	-1,717,913 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$27.85 - $34.49 $47.6 Million - $58.9 Million	1,707,673 Added 16676.49%	1,717,913 $50.6 Million
Q4 2020 Feb 16, 2021	BUY	$27.53 - $33.79 $281,907 - $346,009	10,240 New	10,240 $314,000

443

474M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.7B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.